首页 > 最新文献

Ceska Gynekologie-Czech Gynaecology最新文献

英文 中文
Physiotherapy in a patient with diastasis of the rectus abdominis muscle after childbirth. 分娩后腹直肌转移患者的物理治疗。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023180
Rastislav Dudič, Eva Vaská

Background: Examination for the presence of diastasis of the rectus abdominis muscle and examination of the entire posture is very important in postpartum women. Currently, examination by 2D ultrasound, caliper and palpation is used. It is examined at rest and during stress tests.

Methods: Case study of a patient with diastasis of the direct abdominal muscle after a first spontaneous uncomplicated delivery at the age of 32 years. Examination to confirm diastasis of the rectus abdominis muscle - the width of linea alba was measured with a 2D linear probe by ultrasound 4.5 cm above the umbilicus, in the region of the umbilicus and 4.5 cm below the umbilicus. Lying on the back at rest, and with elevation of the lower limbs. The degree of severity was classified into four grades. A standard physiotherapy postural examination was performed. A part of the intervention was individual exercise with activation of the m. transversus abdominis to reduce diastasis of the direct abdominal muscles. The exercise program included postural adjustment, modification of breathing stereotype and quality, and activation of pelvic floor muscles. Exercises to reduce pain in the ligamentous apparatus and training in correct ergonomics were also performed. The dosage of exercise was 15 min per day in the 1st week of treatment, 2-4 week of treatment 20 min per day, 5-12 week of treatment 30 min per day, 5 days per week, for 12 weeks.

Conclusion: The effect of exercise with activation of m. transversus abdominis on the reduction of diastasis of the direct abdominal muscle in the postpartum patient was objectively proven by the above mentioned objectification methods.

背景:检查腹直肌转移的存在和检查整个姿势对产后妇女是非常重要的。目前主要采用二维超声、卡尺和触诊检查。它在休息和压力测试中被检查。方法:对一例32岁首次自然无并发症分娩后直接腹肌转移的患者进行病例分析。检查确认腹直肌分离-在脐上方4.5 cm,脐区域和脐下方4.5 cm处用超声二维线性探头测量白线宽度。休息时仰卧,下肢抬高。严重程度被分为四个等级。进行标准的物理治疗体位检查。干预的一部分是激活m的个人运动。腹横肌,减少腹直肌的分散。运动项目包括姿势调整、呼吸模式和呼吸质量的改变以及盆底肌肉的激活。还进行了减轻韧带装置疼痛的练习和正确的人体工程学训练。运动剂量:治疗1周15 min /天,治疗2-4周20 min /天,治疗5-12周30 min /天,每周5天,共12周。结论:运动对m的激活作用。通过上述物化方法,客观地证明了经腹对产后直腹肌转移的减少作用。
{"title":"Physiotherapy in a patient with diastasis of the rectus abdominis muscle after childbirth.","authors":"Rastislav Dudič,&nbsp;Eva Vaská","doi":"10.48095/cccg2023180","DOIUrl":"https://doi.org/10.48095/cccg2023180","url":null,"abstract":"<p><strong>Background: </strong>Examination for the presence of diastasis of the rectus abdominis muscle and examination of the entire posture is very important in postpartum women. Currently, examination by 2D ultrasound, caliper and palpation is used. It is examined at rest and during stress tests.</p><p><strong>Methods: </strong>Case study of a patient with diastasis of the direct abdominal muscle after a first spontaneous uncomplicated delivery at the age of 32 years. Examination to confirm diastasis of the rectus abdominis muscle - the width of linea alba was measured with a 2D linear probe by ultrasound 4.5 cm above the umbilicus, in the region of the umbilicus and 4.5 cm below the umbilicus. Lying on the back at rest, and with elevation of the lower limbs. The degree of severity was classified into four grades. A standard physiotherapy postural examination was performed. A part of the intervention was individual exercise with activation of the m. transversus abdominis to reduce diastasis of the direct abdominal muscles. The exercise program included postural adjustment, modification of breathing stereotype and quality, and activation of pelvic floor muscles. Exercises to reduce pain in the ligamentous apparatus and training in correct ergonomics were also performed. The dosage of exercise was 15 min per day in the 1st week of treatment, 2-4 week of treatment 20 min per day, 5-12 week of treatment 30 min per day, 5 days per week, for 12 weeks.</p><p><strong>Conclusion: </strong>The effect of exercise with activation of m. transversus abdominis on the reduction of diastasis of the direct abdominal muscle in the postpartum patient was objectively proven by the above mentioned objectification methods.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 3","pages":"180-185"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10073793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assisted oocyte activation. 辅助卵母细胞激活
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023459
Pavel Trávník, Michal Ješeta, Renata Hűttelová, Radomír Křen, Lukáš Landsmann, Andrea Nesvadbová, Gabriela Tauwinklová

Objective: Currently, there is a rapid increase in studies on assisted oocyte activation, which can significantly improve the process of in vitro fertilization. Fertilization of oocytes by conventional methods and by intracytoplasmic sperm injection can be affected by insufficient activation of the oocyte. The reason is mainly deviations in the enzymatic equipment of sperm or oocytes or a non-functional activation cascade. In many cases, fertilization can be achieved using artificial oocyte activation by applying calcium ion donors to the oocytes after sperm microinjection. However, opinions on the safety and reliability of this method are not uniform. The aim of the thesis is to present current knowledge about assisted oocyte activation and its impact not only on in vitro fertilization, but also on subsequent embryonic and fetal development.

Methodology: Research of relevant literature in Web of Science, PubMed/Medline and Scopus databases.

Results and conclusions: Based on the literature data and the authors' own experience, it follows that this method is effective and safe from the point of view of further development of the embryo, fetus and postnatal development. Extensive meta-analyses focused on this method were carried out, which did not find a negative impact not only on the embryonic and fetal development of the individual, but this method did not have associated with a negative impact on the psychosomatic development of the children.

目的:目前,有关卵母细胞辅助激活的研究迅速增加,这可以显著改善体外受精过程。用传统方法和卵胞浆内单精子注射法使卵母细胞受精,会因卵母细胞活化不足而受到影响。究其原因,主要是精子或卵母细胞的酶设备出现偏差,或激活级联功能失效。在许多情况下,通过在精子显微注射后向卵母细胞施用钙离子供体,可以实现人工卵母细胞活化受精。然而,对这种方法的安全性和可靠性的看法并不一致。本论文旨在介绍目前有关辅助卵母细胞活化的知识及其不仅对体外受精,而且对后续胚胎和胎儿发育的影响:方法:在 Web of Science、PubMed/Medline 和 Scopus 数据库中研究相关文献:根据文献数据和作者自身的经验,从胚胎、胎儿和产后发育的角度来看,这种方法是有效和安全的。作者对这种方法进行了广泛的荟萃分析,结果表明,这种方法不仅不会对胚胎和胎儿的发育产生负面影响,也不会对儿童的心理发育产生负面影响。
{"title":"Assisted oocyte activation.","authors":"Pavel Trávník, Michal Ješeta, Renata Hűttelová, Radomír Křen, Lukáš Landsmann, Andrea Nesvadbová, Gabriela Tauwinklová","doi":"10.48095/cccg2023459","DOIUrl":"10.48095/cccg2023459","url":null,"abstract":"<p><strong>Objective: </strong>Currently, there is a rapid increase in studies on assisted oocyte activation, which can significantly improve the process of in vitro fertilization. Fertilization of oocytes by conventional methods and by intracytoplasmic sperm injection can be affected by insufficient activation of the oocyte. The reason is mainly deviations in the enzymatic equipment of sperm or oocytes or a non-functional activation cascade. In many cases, fertilization can be achieved using artificial oocyte activation by applying calcium ion donors to the oocytes after sperm microinjection. However, opinions on the safety and reliability of this method are not uniform. The aim of the thesis is to present current knowledge about assisted oocyte activation and its impact not only on in vitro fertilization, but also on subsequent embryonic and fetal development.</p><p><strong>Methodology: </strong>Research of relevant literature in Web of Science, PubMed/Medline and Scopus databases.</p><p><strong>Results and conclusions: </strong>Based on the literature data and the authors' own experience, it follows that this method is effective and safe from the point of view of further development of the embryo, fetus and postnatal development. Extensive meta-analyses focused on this method were carried out, which did not find a negative impact not only on the embryonic and fetal development of the individual, but this method did not have associated with a negative impact on the psychosomatic development of the children.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 6","pages":"459-462"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy termination indications and outcomes before 24 weeks of gestation - a case series. 妊娠 24 周前终止妊娠的指征和结果--病例系列。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023428
Şükran Doğru, Fatih Akkuş, Aslı A. Atci, Arif Caner Erdoğan, Ali Acar

Objective: This study aimed to assess termination of pregnancy (TOP) indications and obstetric outcomes before the 24th gestational week.

Materials and methods: This is a retrospective study that includes terminations performed in singleton pregnancies between December 2021 and December 2022 in the Perinatology Clinic of Necmettin Erbakan University Meram Medical Faculty. According to the reasons for TOP, all patients were divided into three groups: maternal, fetal, and obstetric reasons. The termination approach and outcomes were evaluated in all cases.

Results: A total of 210 patients were included in the study. Considering termination indications, 18 (8.5%) patients had maternal causes, 127 (60.5%) had fetal causes, and 65 (31%) had obstetric causes. Maternal causes were significantly higher in the 1st trimester and fetal causes in the 2nd trimester (P = 0.001). In the maternal group, 77.8% dilatation and curettage were used, 70.1% misoprostol and 29.9% misoprostol + Foley catheter in the fetal group, and 66.2% misoprostol in the obstetric group (P = 0.0001). The length of hospital stay and recurrent revision curettage were not statistically different between the fetal, maternal, and obstetric groups (P = 0.099, P = 0.8, respectively).

Conclusion: Termination options should be offered for complicated pregnancies due to fetal, maternal, or obstetric reasons. Pregnancy termination week and indication affect morbidity.

目的:本研究旨在评估妊娠 24 周前终止妊娠(TOP)的适应症和产科结果:本研究旨在评估第24孕周前终止妊娠(TOP)的适应症和产科结果:这是一项回顾性研究,包括 2021 年 12 月至 2022 年 12 月期间在内克梅廷-埃尔巴坎大学梅拉姆医学院围产期诊所实施的单胎妊娠终止手术。根据终止妊娠的原因,所有患者被分为三组:母体原因、胎儿原因和产科原因。对所有病例的终止妊娠方法和结果进行了评估:共有 210 名患者参与了研究。考虑到终止妊娠的原因,18 例(8.5%)患者为母体原因,127 例(60.5%)患者为胎儿原因,65 例(31%)患者为产科原因。母体原因在妊娠头三个月明显较多,胎儿原因在妊娠后三个月明显较多(P = 0.001)。在母体组中,77.8%使用了扩张和刮宫术,在胎儿组中,70.1%使用了米索前列醇,29.9%使用了米索前列醇+福里导管,在产科组中,66.2%使用了米索前列醇(P = 0.0001)。胎儿组、母体组和产科组的住院时间和复发改刮宫术无统计学差异(P = 0.099,P = 0.8):结论:因胎儿、母体或产科原因导致的复杂妊娠应选择终止妊娠。终止妊娠的周数和指征对发病率有影响。
{"title":"Pregnancy termination indications and outcomes before 24 weeks of gestation - a case series.","authors":"Şükran Doğru, Fatih Akkuş, Aslı A. Atci, Arif Caner Erdoğan, Ali Acar","doi":"10.48095/cccg2023428","DOIUrl":"10.48095/cccg2023428","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess termination of pregnancy (TOP) indications and obstetric outcomes before the 24th gestational week.</p><p><strong>Materials and methods: </strong>This is a retrospective study that includes terminations performed in singleton pregnancies between December 2021 and December 2022 in the Perinatology Clinic of Necmettin Erbakan University Meram Medical Faculty. According to the reasons for TOP, all patients were divided into three groups: maternal, fetal, and obstetric reasons. The termination approach and outcomes were evaluated in all cases.</p><p><strong>Results: </strong>A total of 210 patients were included in the study. Considering termination indications, 18 (8.5%) patients had maternal causes, 127 (60.5%) had fetal causes, and 65 (31%) had obstetric causes. Maternal causes were significantly higher in the 1st trimester and fetal causes in the 2nd trimester (P = 0.001). In the maternal group, 77.8% dilatation and curettage were used, 70.1% misoprostol and 29.9% misoprostol + Foley catheter in the fetal group, and 66.2% misoprostol in the obstetric group (P = 0.0001). The length of hospital stay and recurrent revision curettage were not statistically different between the fetal, maternal, and obstetric groups (P = 0.099, P = 0.8, respectively).</p><p><strong>Conclusion: </strong>Termination options should be offered for complicated pregnancies due to fetal, maternal, or obstetric reasons. Pregnancy termination week and indication affect morbidity.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 6","pages":"428-434"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relugolix combination therapy and symptoms of uterine myomatosis - selected case reports of indication spectrum and treatment outcomes. Relugolix联合治疗和子宫肌瘤病的症状——选择适应证谱和治疗结果的病例报告。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023359
Robert Hudeček, Jaroslav Klát, Karel Pohl, Aleš Prokopenko, Lubomír Mikulášek, Soňa Šimová, Petr Krčál, Aleš Ševčík, Pavel Tomeš

Objective: An illustrative review of the indications for relugolix combination therapy (RCT) in the management of symptoms associated with uterine myomatosis.

Methods: A set of annotated case reports from outpatient and clinical practice.

Results: The file includes a non-invasive methodology for defining excessive menstrual bleeding using the pictorial bleeding assessment chart (PBAC). It also presents the use of RCT as a fertility-sparing procedure prior to elective myomectomy and the management of isthmic fibroids as an uterine factor of infertility. Cases of RCT of adenomyosis in primary sterility and in extragenital forms of endometriosis are commented. Emergent events associated with complications of myomatosis in pregnancy are represented by a case report of necrotizing diff use myomatosis in puerperium. The differential-diagnostic confusion of adnexal pathology and myomatosis, RCT as a final solution to failed pharmacotherapy, and the alternative of hysterectomy in premenopause illustrate the diverse spectrum of indications for pharmacological treatment, including the possibility of dual therapy with RCT and aGnRH.

Conclusion: Relugolix combination therapy as an effective and safe causal treatment expands the therapeutic spectrum and options for reproductive medicine specialists and registering gynaecologists. The availability of conservative treatment in combination with surgical treatment leads to optimalization and greater effectiveness of therapeutic procedures and increased quality of life for women with myomatosis.

目的:对雷鲁戈利联合治疗(RCT)治疗子宫肌瘤相关症状的适应证进行说明性综述。方法:一组来自门诊和临床实践的带注释的病例报告。结果:该文件包括一种使用出血评估图表(PBAC)定义月经过多出血的非侵入性方法。它还介绍了在选择性子宫肌瘤切除术前使用RCT作为一种保留生育能力的手术,以及将峡部肌瘤作为不孕的子宫因素进行治疗。对原发性不孕和生殖器外子宫内膜异位症子宫腺肌症的RCT病例进行了评论。妊娠期与子宫肌瘤病并发症相关的突发事件以产褥期坏死性不同用途子宫肌瘤病的病例报告为代表。附件病理学和子宫肌瘤病的鉴别诊断混乱,RCT作为药物治疗失败的最终解决方案,以及绝经前子宫切除术的替代方案,说明了药物治疗的不同适应症,包括RCT和aGnRH双重治疗的可能性。结论:Relugolix联合治疗作为一种有效、安全的因果治疗方法,扩大了生殖医学专家和注册妇科医生的治疗范围和选择。保守治疗与手术治疗相结合的可用性可使子宫肌瘤病患者的治疗程序最优化和更有效,并提高生活质量。
{"title":"Relugolix combination therapy and symptoms of uterine myomatosis - selected case reports of indication spectrum and treatment outcomes.","authors":"Robert Hudeček, Jaroslav Klát, Karel Pohl, Aleš Prokopenko, Lubomír Mikulášek, Soňa Šimová, Petr Krčál, Aleš Ševčík, Pavel Tomeš","doi":"10.48095/cccg2023359","DOIUrl":"10.48095/cccg2023359","url":null,"abstract":"<p><strong>Objective: </strong>An illustrative review of the indications for relugolix combination therapy (RCT) in the management of symptoms associated with uterine myomatosis.</p><p><strong>Methods: </strong>A set of annotated case reports from outpatient and clinical practice.</p><p><strong>Results: </strong>The file includes a non-invasive methodology for defining excessive menstrual bleeding using the pictorial bleeding assessment chart (PBAC). It also presents the use of RCT as a fertility-sparing procedure prior to elective myomectomy and the management of isthmic fibroids as an uterine factor of infertility. Cases of RCT of adenomyosis in primary sterility and in extragenital forms of endometriosis are commented. Emergent events associated with complications of myomatosis in pregnancy are represented by a case report of necrotizing diff use myomatosis in puerperium. The differential-diagnostic confusion of adnexal pathology and myomatosis, RCT as a final solution to failed pharmacotherapy, and the alternative of hysterectomy in premenopause illustrate the diverse spectrum of indications for pharmacological treatment, including the possibility of dual therapy with RCT and aGnRH.</p><p><strong>Conclusion: </strong>Relugolix combination therapy as an effective and safe causal treatment expands the therapeutic spectrum and options for reproductive medicine specialists and registering gynaecologists. The availability of conservative treatment in combination with surgical treatment leads to optimalization and greater effectiveness of therapeutic procedures and increased quality of life for women with myomatosis.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 5","pages":"359-370"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71487166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of human papillomavirus vaccination in the prevention of recurrence of severe cervical lesions. 人乳头瘤病毒疫苗预防严重宫颈病变复发的疗效。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023294
Borek Sehnal, Tomáš Pichlík, Michael J Halaška, Monika Větrovská, Anna Babková, Jana Drozenová, Helena Robová, Lukáš Rob

Objective: A review of current knowledge on the efficacy of human papillomavirus (HPV) vaccination in preventing recurrent severe cervical lesions after excisional surgical treatment.

Methods and results: HPV infection is necessary for the development of most cervical precancerous lesions and cervical cancers. Currently, three prophylactic vaccines against HPV infection are available on the market: bivalent Cervarix, quadrivalent Gardasil (formerly Silgard) and nonavalent Gardasil9. All three prophylactic vaccines show high effect in preventing the development of precancerous lesions. The highest efficacy is achieved in the HPV naive population. The surgical excision of severe cervical precancers is the standard approach. However, guidelines regarding HPV vaccination at the time of conisation are not clearly determined. Women diagnosed with severe cervical lesions have mostly not been vaccinated against HPV so far. Therefore, it is beneficial to understand the importance and efficacy of HPV vaccination at the time of conisation in preventing recurrent precancerous lesions. The exact value of HPV vaccination in the context of surgical excision of precancerous lesions remains unclear, but vaccination is definitely valuable in reducing the risk of recurrence. Vaccination timing seems to be more favorable before surgery. However, the ideal timing of vaccination is not established. Some of these questions are likely to be answered by the results of ongoing randomized controlled trials.

Conclusion: Adjuvant HPV vaccination in the setting of surgical treatment for cervical precancerous lesion is significantly associated with a reduced risk of recurrence. HPV vaccination should be strongly considered as adjuvant therapy, especially in young patients undergoing conisation for a severe cervical lesion.

目的:综述目前关于接种人乳头瘤病毒(HPV)预防宫颈切除术后严重病变复发的疗效。方法和结果:HPV感染对于大多数宫颈癌前病变和宫颈癌的发展是必要的。目前,市场上有三种预防HPV感染的疫苗:二价Cervarix、四价Gardasil(原Silgard)和无价Gardasil9。这三种预防性疫苗在预防癌前病变的发展方面都显示出很高的效果。在HPV幼稚人群中达到最高的疗效。手术切除严重的宫颈癌前病变是标准的方法。然而,在接种HPV疫苗时的指导方针并没有明确规定。迄今为止,被诊断患有严重宫颈病变的妇女大多没有接种HPV疫苗。因此,了解HPV疫苗接种在预防癌前病变复发时的重要性和有效性是有益的。在手术切除癌前病变的背景下,HPV疫苗接种的确切价值尚不清楚,但疫苗接种在降低复发风险方面肯定是有价值的。在手术前接种疫苗似乎更有利。然而,理想的疫苗接种时间尚未确定。其中一些问题可能会通过正在进行的随机对照试验的结果得到回答。结论:在宫颈癌前病变手术治疗的背景下,佐剂HPV疫苗接种与降低复发风险显著相关。应强烈考虑HPV疫苗接种作为辅助治疗,特别是在接受严重宫颈病变的年轻患者中。
{"title":"The efficacy of human papillomavirus vaccination in the prevention of recurrence of severe cervical lesions.","authors":"Borek Sehnal,&nbsp;Tomáš Pichlík,&nbsp;Michael J Halaška,&nbsp;Monika Větrovská,&nbsp;Anna Babková,&nbsp;Jana Drozenová,&nbsp;Helena Robová,&nbsp;Lukáš Rob","doi":"10.48095/cccg2023294","DOIUrl":"https://doi.org/10.48095/cccg2023294","url":null,"abstract":"<p><strong>Objective: </strong>A review of current knowledge on the efficacy of human papillomavirus (HPV) vaccination in preventing recurrent severe cervical lesions after excisional surgical treatment.</p><p><strong>Methods and results: </strong>HPV infection is necessary for the development of most cervical precancerous lesions and cervical cancers. Currently, three prophylactic vaccines against HPV infection are available on the market: bivalent Cervarix, quadrivalent Gardasil (formerly Silgard) and nonavalent Gardasil9. All three prophylactic vaccines show high effect in preventing the development of precancerous lesions. The highest efficacy is achieved in the HPV naive population. The surgical excision of severe cervical precancers is the standard approach. However, guidelines regarding HPV vaccination at the time of conisation are not clearly determined. Women diagnosed with severe cervical lesions have mostly not been vaccinated against HPV so far. Therefore, it is beneficial to understand the importance and efficacy of HPV vaccination at the time of conisation in preventing recurrent precancerous lesions. The exact value of HPV vaccination in the context of surgical excision of precancerous lesions remains unclear, but vaccination is definitely valuable in reducing the risk of recurrence. Vaccination timing seems to be more favorable before surgery. However, the ideal timing of vaccination is not established. Some of these questions are likely to be answered by the results of ongoing randomized controlled trials.</p><p><strong>Conclusion: </strong>Adjuvant HPV vaccination in the setting of surgical treatment for cervical precancerous lesion is significantly associated with a reduced risk of recurrence. HPV vaccination should be strongly considered as adjuvant therapy, especially in young patients undergoing conisation for a severe cervical lesion.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 4","pages":"294-300"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10119696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute recurrent pancreatitis during 3rd trimester of pregnancy. 妊娠晚期急性复发性胰腺炎。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg202317
Jakub Tobola, Martin Němec, Petronela Bieliková

Objective: We present an unusual case report of a pregnant patient with recurrent attacks of acute pancreatitis due to cholecystolithiasis.

Conclusion: Acute pancreatitis in pregnancy is a rare disease. Unlike the non-pregnant population, it is characterized by a high recurrence rate. Acute pancreatitis during pregnancy has a negative effect on both the mother and the fetus. The treatment is modified depending on the trimester of pregnancy.

目的:我们提出一个不寻常的病例报告妊娠患者反复发作急性胰腺炎由于胆囊结石。结论:妊娠期急性胰腺炎是一种罕见的疾病。与未怀孕人群不同,它的特点是复发率高。妊娠期急性胰腺炎对母亲和胎儿都有不良影响。治疗方法根据怀孕的三个月进行调整。
{"title":"Acute recurrent pancreatitis during 3rd trimester of pregnancy.","authors":"Jakub Tobola,&nbsp;Martin Němec,&nbsp;Petronela Bieliková","doi":"10.48095/cccg202317","DOIUrl":"https://doi.org/10.48095/cccg202317","url":null,"abstract":"<p><strong>Objective: </strong>We present an unusual case report of a pregnant patient with recurrent attacks of acute pancreatitis due to cholecystolithiasis.</p><p><strong>Conclusion: </strong>Acute pancreatitis in pregnancy is a rare disease. Unlike the non-pregnant population, it is characterized by a high recurrence rate. Acute pancreatitis during pregnancy has a negative effect on both the mother and the fetus. The treatment is modified depending on the trimester of pregnancy.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 1","pages":"17-19"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10823789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-Müllerian hormone - clinical use and future possibilities. 抗<s:1>勒氏杆菌激素-临床应用及未来可能性。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023126
Olga Dubová, Michal Zikán

Anti-Müllerian hormone (AMH) is a protein produced already in human fetus. It has an essential role in the differentiation of the reproductive tract, regulation of the ovaries and testes. The determination of serum AMH levels is used in clinical practice. Today, especially in reproductive medicine in the assessment of ovarian reserve and in the prediction of the response to ovarian stimulation. However, in young cancer patients, it can also predict the risk of ovarian failure after anticancer treatment. It finds further use in pediatric endocrinology in the diagnosis of sexual differentiation disorders. In oncology, it is used as a tumor marker for monitoring patients with granulosa tumors. In the future, however, it is also promising to use the knowledge of AMH function for the treatment of gynecological as well as other solid malignancies expressing a tissue-specific receptor for AMH.

勒氏杆菌激素(AMH)是人类胎儿体内已经产生的一种蛋白质。它在生殖道的分化、卵巢和睾丸的调节中起着重要的作用。血清AMH水平的测定用于临床实践。今天,特别是在生殖医学中评估卵巢储备和预测对卵巢刺激的反应。然而,在年轻的癌症患者中,它也可以预测抗癌治疗后卵巢功能衰竭的风险。它发现在儿科内分泌学在诊断性别分化障碍进一步使用。在肿瘤学中,它被用作监测颗粒性肿瘤患者的肿瘤标志物。然而,在未来,利用AMH功能的知识来治疗妇科以及其他表达AMH组织特异性受体的实体恶性肿瘤也是有希望的。
{"title":"Anti-Müllerian hormone - clinical use and future possibilities.","authors":"Olga Dubová,&nbsp;Michal Zikán","doi":"10.48095/cccg2023126","DOIUrl":"https://doi.org/10.48095/cccg2023126","url":null,"abstract":"<p><p>Anti-Müllerian hormone (AMH) is a protein produced already in human fetus. It has an essential role in the differentiation of the reproductive tract, regulation of the ovaries and testes. The determination of serum AMH levels is used in clinical practice. Today, especially in reproductive medicine in the assessment of ovarian reserve and in the prediction of the response to ovarian stimulation. However, in young cancer patients, it can also predict the risk of ovarian failure after anticancer treatment. It finds further use in pediatric endocrinology in the diagnosis of sexual differentiation disorders. In oncology, it is used as a tumor marker for monitoring patients with granulosa tumors. In the future, however, it is also promising to use the knowledge of AMH function for the treatment of gynecological as well as other solid malignancies expressing a tissue-specific receptor for AMH.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 2","pages":"126-130"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9482332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specifics of infertility treatment in women with premature ovarian failure. 卵巢早衰妇女不孕治疗的具体情况。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023131
Monika Poláková

Premature ovarian failure (POF, POI - premature ovarian insufficiency) is a serious situation for a woman with reproductive plans that more or less precludes having her own bio-logical child. In addition to the lack of functional oocytes in the ovaries, it is also a premature lack of sex hormones, which has an overall negative effect on health. The article guides us through care both in the clinic of the gynecologist and through treatment in the center of reproductive medicine. The dia-gnosis and treatment of POF illustrates some endocrinological principles and connections.

卵巢早衰(POF, POI—卵巢功能不全)是一种严重的情况,对于有生育计划的妇女来说,这或多或少地排除了她自己的生物孩子。除了卵巢中缺乏功能性卵母细胞外,还过早缺乏性激素,这对健康有整体负面影响。这篇文章指导我们在妇科医生的门诊和生殖医学中心的治疗中进行护理。POF的诊断和治疗说明了一些内分泌原理和联系。
{"title":"Specifics of infertility treatment in women with premature ovarian failure.","authors":"Monika Poláková","doi":"10.48095/cccg2023131","DOIUrl":"https://doi.org/10.48095/cccg2023131","url":null,"abstract":"<p><p>Premature ovarian failure (POF, POI - premature ovarian insufficiency) is a serious situation for a woman with reproductive plans that more or less precludes having her own bio-logical child. In addition to the lack of functional oocytes in the ovaries, it is also a premature lack of sex hormones, which has an overall negative effect on health. The article guides us through care both in the clinic of the gynecologist and through treatment in the center of reproductive medicine. The dia-gnosis and treatment of POF illustrates some endocrinological principles and connections.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 2","pages":"131-134"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9762428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Termination of Pregnancy (MToP) in the 1st trimester - the role of human chorionic gonadotropin and ultrasound in pregnancy diagnosis and MToP follow-up. 妊娠头三个月的医学终止妊娠(MToP)--人绒毛膜促性腺激素和超声波在妊娠诊断和医学终止妊娠随访中的作用。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023420
Vladimir Dvořák, Petra Slunska, Michaela Maděrková Tozzi, Katerina Langová, Vladimira Kroutilova, Radovan Pilka, Marek Ľubušký

Objective: In the Czech Republic, it is possible, to carry out Medical Termination of Pregnancy (MToP) in the 1st trimester up until the 49th day of secondary amenorrhea. The aim of the study is to analyse the significance of serum/urine human chorionic gonadotropin (hCG) assessment and ultrasound (US) examination in pregnancy diagnosis and MToP follow-up.

Methods: In 2017-2018, MToP was carried out in a total of 109 women by administering a combination of mifepristone (600 mg orally) and misoprostol (400 mcg orally). Serum/urine (LSUP - low sensitivity urine pregnancy test) hCG assessment and US examination were performed at pregnancy diagnosis and MToP follow-up.

Results: At pregnancy diagnosis, there was a positive and medium strong correlation between serum hCG and size of the gestational sac - GS (R = 0.711; P  1,000 IU/L and LSUP test was always positive). In 5.5% of women (6/109), a subsequent surgical intervention was carried out including those with ongoing pregnancy (N = 5); missed abortion (N = 1) was treated by additional misoprostol, where surgical intervention was not necessary.

Conclusion: At pregnancy diagnosis, there is a positive and medium strong correlation between serum hCG and CRL. In MToP follow-up, a negative LSUP test enables reliable exclusion of ongoing pregnancy and missed abortion. In case of a positive LSUP test, US examination should be performed; however, surgical intervention should not be indicated solely on the basis of uterine cavity dilatation.

目的:在捷克共和国,可以在妊娠头三个月至继发性闭经第 49 天进行医学终止妊娠(MToP)。本研究旨在分析血清/尿液人绒毛膜促性腺激素(hCG)评估和超声波(US)检查在妊娠诊断和MToP随访中的意义:2017-2018年,通过口服米非司酮(600毫克)和米索前列醇(400微克)联合用药,共为109名妇女实施了MToP。在妊娠诊断和 MToP 随访时,进行了血清/尿液(LSUP - 低灵敏度尿妊娠试验)hCG 评估和 US 检查:结果:妊娠诊断时,血清 hCG 与孕囊大小--GS 呈中强正相关(R = 0.711;P 1,000 IU/L,LSUP 试验始终呈阳性)。5.5%的妇女(6/109)随后进行了手术治疗,其中包括仍在妊娠的妇女(5 人);对漏流产(1 人)采取了额外的米索前列醇治疗,无需手术治疗:结论:妊娠诊断时,血清 hCG 与 CRL 呈中强正相关。在 MToP 随访中,LSUP 检测阴性可以可靠地排除持续妊娠和漏诊流产。如果 LSUP 检测呈阳性,则应进行 US 检查;但不能仅凭宫腔扩张就进行手术治疗。
{"title":"Medical Termination of Pregnancy (MToP) in the 1st trimester - the role of human chorionic gonadotropin and ultrasound in pregnancy diagnosis and MToP follow-up.","authors":"Vladimir Dvořák, Petra Slunska, Michaela Maděrková Tozzi, Katerina Langová, Vladimira Kroutilova, Radovan Pilka, Marek Ľubušký","doi":"10.48095/cccg2023420","DOIUrl":"10.48095/cccg2023420","url":null,"abstract":"<p><strong>Objective: </strong>In the Czech Republic, it is possible, to carry out Medical Termination of Pregnancy (MToP) in the 1st trimester up until the 49th day of secondary amenorrhea. The aim of the study is to analyse the significance of serum/urine human chorionic gonadotropin (hCG) assessment and ultrasound (US) examination in pregnancy diagnosis and MToP follow-up.</p><p><strong>Methods: </strong>In 2017-2018, MToP was carried out in a total of 109 women by administering a combination of mifepristone (600 mg orally) and misoprostol (400 mcg orally). Serum/urine (LSUP - low sensitivity urine pregnancy test) hCG assessment and US examination were performed at pregnancy diagnosis and MToP follow-up.</p><p><strong>Results: </strong>At pregnancy diagnosis, there was a positive and medium strong correlation between serum hCG and size of the gestational sac - GS (R = 0.711; P  1,000 IU/L and LSUP test was always positive). In 5.5% of women (6/109), a subsequent surgical intervention was carried out including those with ongoing pregnancy (N = 5); missed abortion (N = 1) was treated by additional misoprostol, where surgical intervention was not necessary.</p><p><strong>Conclusion: </strong>At pregnancy diagnosis, there is a positive and medium strong correlation between serum hCG and CRL. In MToP follow-up, a negative LSUP test enables reliable exclusion of ongoing pregnancy and missed abortion. In case of a positive LSUP test, US examination should be performed; however, surgical intervention should not be indicated solely on the basis of uterine cavity dilatation.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 6","pages":"420-427"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139088887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention of intrauterine adhesions. 预防宫内粘连。
IF 0.4 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2023-01-01 DOI: 10.48095/cccg2023210
Michal Emingr, Matúš Halaj, Michal Malčák, Jiří Hanáček

Intrauterine adhesions are a serious complication that occurs after intrauterine procedures, most often in connection with pregnancy. Manifestations such as amenorrhea, pelvic pain, and infertility for a woman, especially in reproductive age, are serious and together with intrauterine adhesions we call them Asherman's syndrome. Primary prevention after intrauterine procedures is important. Published studies show that the use of hyaluronic acid gel, especially after abortions, leads to the prevention of moderate and severe intrauterine adhesions and also increases the pregnancy rate.

宫腔粘连是宫腔手术后发生的严重并发症,通常与妊娠有关。闭经、盆腔疼痛和不孕等症状对女性,尤其是育龄期的女性来说,都是很严重的,并伴有宫腔粘连,我们称之为阿什曼综合征。宫内手术后的一级预防很重要。已发表的研究表明,使用透明质酸凝胶,特别是在流产后,可以预防中度和重度宫腔粘连,也可以提高怀孕率。
{"title":"Prevention of intrauterine adhesions.","authors":"Michal Emingr,&nbsp;Matúš Halaj,&nbsp;Michal Malčák,&nbsp;Jiří Hanáček","doi":"10.48095/cccg2023210","DOIUrl":"https://doi.org/10.48095/cccg2023210","url":null,"abstract":"<p><p>Intrauterine adhesions are a serious complication that occurs after intrauterine procedures, most often in connection with pregnancy. Manifestations such as amenorrhea, pelvic pain, and infertility for a woman, especially in reproductive age, are serious and together with intrauterine adhesions we call them Asherman's syndrome. Primary prevention after intrauterine procedures is important. Published studies show that the use of hyaluronic acid gel, especially after abortions, leads to the prevention of moderate and severe intrauterine adhesions and also increases the pregnancy rate.</p>","PeriodicalId":43333,"journal":{"name":"Ceska Gynekologie-Czech Gynaecology","volume":"88 3","pages":"210-213"},"PeriodicalIF":0.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9675967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ceska Gynekologie-Czech Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1